Clinical trials
Terminated Phase 2 Scleroderma, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2021 | 5 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Celgene | 1 |
| Charite University, Berlin, Germany | 1 |
| Corbus Pharmaceuticals Inc. | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Georgetown University | 1 |
| Heidelberg University | 1 |
| Kadmon, a Sanofi Company | 1 |
| Lakefront Biotherapeutics NV | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 17 |
| Scleroderma, Diffuse | 7 |
| Lung Diseases, Interstitial | 3 |
| Hypertension, Pulmonary | 2 |
| Pulmonary Fibrosis | 2 |
| Raynaud Disease | 2 |
| Arthritis, Juvenile | 1 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
| COVID-19 | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.